The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution

Influenza virus inflicts a heavy death toll annually and resistance to existing antiviral drugs has generated interest in the development of agents with novel mechanisms of action. Favipiravir is an antiviral drug that acts by increasing the genome-wide mutation rate of influenza A virus (IAV). Pote...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Genome Biol Evol
Auteurs principaux: Ormond, Louise, Liu, Ping, Matuszewski, Sebastian, Renzette, Nicholas, Bank, Claudia, Zeldovich, Konstantin, Bolon, Daniel N., Kowalik, Timothy F., Finberg, Robert W., Jensen, Jeffrey D., Wang, Jennifer P.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5570085/
https://ncbi.nlm.nih.gov/pubmed/28854600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gbe/evx138
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires